Group One Trading
BEAM icon

Group One Trading’s Beam Therapeutics BEAM Stock Holding History

Group One Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
69,700
+56,100
+413% +$1.56M ﹤0.01% 2236
2025
Q4 		$377K Sell
13,600
-24,900
-65% -$635K ﹤0.01% 3794
2025
Q3 		$934K Buy
38,500
+19,400
+102% +$386K ﹤0.01% 3107
2025
Q2 		$325K Sell
19,100
-14,100
-42% -$246K ﹤0.01% 3840
2025
Q1 		$648K Sell
33,200
-300
-0.9% -$7.86K ﹤0.01% 2845
2024
Q4 		$831K Sell
33,500
-5,700
-15% -$145K ﹤0.01% 2741
2024
Q3 		$960K Buy
39,200
+13,300
+51% +$344K ﹤0.01% 2325
2024
Q2 		$607K Buy
25,900
+1,000
+4% +$24.6K ﹤0.01% 2385
2024
Q1 		$823K Buy
24,900
+9,700
+64% +$302K ﹤0.01% 2262
2023
Q4 		$414K Sell
15,200
-9,500
-38% -$236K ﹤0.01% 3228
2023
Q3 		$594K Buy
24,700
+2,900
+13% +$77.7K ﹤0.01% 2742
2023
Q2 		$696K Buy
21,800
+1,400
+7% +$45.4K ﹤0.01% 2690
2023
Q1 		$625K Buy
20,400
+20,300
+20,300% +$801K ﹤0.01% 2552
2022
Q4 		$3.91K Sell
100
-122,500
-100% -$5.49M ﹤0.01% 6434
2022
Q3 		$5.84M Buy
122,600
+121,300
+9,331% +$6.92M 0.01% 1049
2022
Q2 		$50K Sell
1,300
-12,600
-91% -$501K ﹤0.01% 5546
2022
Q1 		$796K Buy
13,900
+3,100
+29% +$203K ﹤0.01% 3319
2021
Q4 		$861K Sell
10,800
-2,200
-17% -$188K ﹤0.01% 3512
2021
Q3 		$1.13M Sell
13,000
-152,500
-92% -$15.3M ﹤0.01% 3281
2021
Q2 		$21.3M Sell
165,500
-60,800
-27% -$4.84M 0.03% 590
2021
Q1 		$18.1M Buy
226,300
+225,700
+37,617% +$21.5M 0.03% 587
2020
Q4 		$49K Buy
+600
New +$29.5K ﹤0.01% 5015

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Group One Trading's BEAM Position: Q1 2026 in Review

Group One Trading reduced its Beam Therapeutics (BEAM) stake by 64% in Q1 2026, selling an estimated $159K and leaving 3,216 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4948.

Group One Trading first reported a position in BEAM in Q4 2020 and has held it in 12 quarters since. The position peaked at $5.32M in Q1 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Group One Trading held 3,216 shares of Beam Therapeutics worth $76.6K as of Q1 2026.
  • Group One Trading sold 5,736 Beam Therapeutics shares in Q1 2026, an estimated $159K.
  • Beam Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4948 holding.
  • Group One Trading first reported a position in Beam Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • Group One Trading's Beam Therapeutics position peaked at $5.32M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.